FDA

Latest FDA Items
  • Biotech to bring home the bacon?

    Biotechnology is everywhere these days, from the production of pest-resistant crops to microorganisms that make biofuels to new drugs and vaccines. It's even used to produce animals with novel and valuable traits, but these applications in particular are suffering from inconsistent, uncertain regulation.


  • Terminally ill lose case for shot at experimental drugs

    ASSOCIATED PRESS


  • Anemia drugs limited by CMS

    The federal agency in charge of Medicare dealt a blow to the drug industry this week by restricting the use of popular anemia drugs, considered by many to be over-prescribed.


  • Drug-safety 'advocates'

    Earlier this week, a joint session of two Food and Drug Administration advisory committees recommended that Avandia, one of two drugs that reduce insulin resistance, stay on the market with added information about which patients should avoid taking the medicine in order to reduce the risk of heart attacks. The recommendation, based on a careful evaluation of a massive amount of data, focused on whether it was possible to tailor the use of Avandia, which has helped people with diabetes stave off blindness, leg amputations and kidney failure, to groups of patients that might be a higher risk for heart problems.


  • FDA labs to remain open until review

    The Food and Drug Administration has suspended its plan to cut half its laboratories until a new Cabinet-level panel finishes its review of ways to ensure the safety of imports, FDA Commissioner Andrew C. von Eschenbach said yesterday.


  • Drug-safety 'advocates'

    Earlier this week, a joint session of two Food and Drug Administration advisory committees recommended that Avandia, one of two drugs that reduce insulin resistance, stay on the market with added information about which patients should avoid taking the medicine in order to reduce the risk of heart attacks. The recommendation, based on a careful evaluation of a massive amount of data, focused on whether it was possible to tailor the use of Avandia, which has helped people with diabetes stave off blindness, leg amputations and kidney failure, to groups of patients that might be a higher risk for heart problems.


  • Panel to weigh Avandia's safety

    A Food and Drug Administration advisory panel is scheduled to meet today to decide the fate of the diabetes drug Avandia.


  • Panel to weigh Avandia's safety

    A Food and Drug Administration advisory panel is scheduled to meet today to decide the fate of the diabetes drug Avandia.


  • Weird science

    Issac Asimov wrote, "The saddest aspect of life right now is that science gathers knowledge faster than society gathers wisdom." What passes for wisdom these days in our nation's capital, so far as science itself is concerned, is an embarrassment of the highest order. Nearly every day the White House, Congress and federal agencies trample scientific facts, accuracy and ethics in their issuance of misguided pronouncements, laws and regulations.


Happening Now